• BX Home
  • Pharmaceutical Approvals: News [Page 13]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL APPROVALS

Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.

Pharmaceutical Approvals is part of Business Exchange, suggested by Evan Rappaport. This topic contains 1,740 news and 318 blog items. Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from like-minded professionals.

News

Recent news on this topic.

MannKind Shares Plunged: What You Need to Knowmore

biggest concern. Instead, investors were focused on what the company had to say about its meeting with the Food and...

FDA Issues First New Rules Under Food Safety Modernization Actmore

Rules to prevent potentially unsafe food from reaching consumers The U.S. Food and Drug Administration recently...

FTC Says Firms Failed to Report Drug Patent Pactmore

to provide guidance to the industry that could serve a broader enforcement purpose. The FTC notified Sanofi, Watson...

Aurobindo Pharma Mulls Spinning Off Unitsmore

firm in a statement to the Bombay Stock Exchange. An employee inspects the bulk-packaging of capsules at Aurobindo...

Risks of Taking Hormonesmore

The synthetic hormone is linked to cancers, infertility and other reproductive problems in their children.

Salix Sued by Partner for "Breach" Over HIV-Associated Drugmore

Three years ago, Salix Pharmaceuticals (Nasdaq: SLXP Morrisville, North Carolina-based Salix paid Napo Pharmaceuticals...

Biotech Stocks: BioMimetic, Mannkind push biotech stocks lowermore

Index (NYSE:DRG) Shares of BioMimetic Therapeutics (NASDAQ:BMTI) On Thursday, an advisory panel of the U.S.

Judge Rules for Ex-Glaxo Lawyemore

proceeding, falsifying and concealing documents and making false statements to the government. Prosecutors alleged her...

Novartis Fires Several Managersmore

ZURICH?Novartis AG on Tuesday confirmed a report that the Swiss pharmaceuticals company has ousted several managers for...

Stocks to Watch: Microsoft, eBay, Dean Foods and Moremore

almost 12% after the company reports a first-quarter loss and says its end-of-review meeting with the U.S.

ADHD Drug Shortages Lead to Hunt for Optionsmore

as the generic she was taking previously. "My performance at work has been reduced," she says.

FDA to issue biosimilar guidance in 2011more

The Food and Drug Administration expects to issue this year general guidance for companies seeking to market generic...

Vital Signs: Regimens: Looking Twice at Supplements for Infantsmore

a survey of women in late pregnancy and through their babies first year of life. Conducted by the Food and Drug...

Summit Business, Howrey, Movie Gallery, Tribune: Bankruptcymore

10231, U.S. Bankruptcy Court, District of Delaware (Wilmington). Updates Molecular Insight Confirms Bondholders���...

Swiss Daybook: ABB Acquires Mincom, UBS Targets, Swiss Lifemore

chief Charles Naylor leaves for HSBC, Finews says *Basilea Pharmaceutica���s antibiotic BAL30072 showed activity...

FDA to issue biosimilar guidelines this yearmore

The Food and Drug Administration expects to issue this year "foundational" guidelines for companies seeking...

FDA official sees drug approvals risingmore

The Food and Drug Administration is seeing a rising number of new drugs ready for approval and expects a gradual...

Stocks to Watch: Oil Price Rise Drives Energy Shares; AIG, Citi Slumpmore

from neutral citing outperformance at Rosetta���s Eagle Ford wells. Rosetta up 21%. ThinkEquity assumed coverage on...

Regimens: Looking Twice at Supplements for Infantsmore

Nearly one in 10 babies are given supplements or plant-based teas to soothe colic or help with teething during the...

Abbott Recalls Device Used to Clip Heart Valvesmore

as soon as possible," Abbott spokesman Jonathon Hamilton said. He said Abbott continues working toward a mid-2011...

Elan to sell drug unit in ��590m dealmore

Extract not available.

FDA News & Notes - Week Of May 9, 2011more

/PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights for this week from the U.S.

Swiss Stocks Fall; UBS, Credit Suisse Retreat, Clariant Advancesmore

Holding AG in Zurich, wrote in a note to clients. ���We expect momentum to pick up again.��� Santhera Pharmaceuticals...

Altman Sees Dealmaking Recoverymore

cyclical upswing,��� said Altman, founder of New York-based investment bank Evercore. Buyers from Applied Materials Inc.

Dabur Scouts for Acquisitionsmore

from Mumbai-based Ajanta Pharma for an undisclosed amount. In December, Dabur had withdrawn its bid for Gujarat-based...

Top Sources: Pharmaceutical Approvals

  • myharvardnews.com
  • pharma-iq.com
  • bloomberg.com
  • Forbes.com
  • pennystockdd.com
  • MarketWatch
  • chicagotribune.com
  • US News
  • Financial Times
  • Reuters

Most Active Users in this Topic

see all contributors in Pharmaceutical Approvals

Featured White Papers

Post a Job

Jobs in this Topic

Occupational Health Nurse For Dsm Pharmaceuticals Vidant Medical Center | Greenville, NC
Posted: May 15
Senior Manager, Global Regulatory Affairs (pharmaceuticals) GE Healthcare | Princeton, NJ
Posted: May 13
Drug Safety Physician Baxter International | Deerfield, IL
Posted: Apr 26
Drug Safety Specialist III Nektar Therapeutics | San Francisco, CA
Posted: May 7

Report comment contains invalid characters. ()
cancel
Search Cancel